Graner MW - Search Results

1

Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro.

Li G, Zeng Y, Chen X, Larmonier N, Sepassi M, Graner MW, Andreansky S, Brewer MA, Katsanis E. Li G, et al. Among authors: graner mw. Clin Exp Immunol. 2007 Apr;148(1):136-45. doi: 10.1111/j.1365-2249.2007.03323.x. Clin Exp Immunol. 2007. PMID: 17349014 Free PMC article.

2

Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity.

Zeng Y, Feng H, Graner MW, Katsanis E. Zeng Y, et al. Among authors: graner mw. Blood. 2003 Jun 1;101(11):4485-91. doi: 10.1182/blood-2002-10-3108. Epub 2003 Feb 6. Blood. 2003. PMID: 12576309 Free article.

3

Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers.

Graner MW, Zeng Y, Feng H, Katsanis E. Graner MW, et al. Cancer Immunol Immunother. 2003 Apr;52(4):226-34. doi: 10.1007/s00262-002-0359-2. Epub 2003 Feb 18. Cancer Immunol Immunother. 2003. PMID: 12669247 Free PMC article.

4

Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl+ murine leukemia.

Zeng Y, Graner MW, Feng H, Li G, Katsanis E. Zeng Y, et al. Among authors: graner mw. Int J Cancer. 2004 Jun 10;110(2):251-9. doi: 10.1002/ijc.20115. Int J Cancer. 2004. PMID: 15069690

5

Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells.

Zeng Y, Graner MW, Thompson S, Marron M, Katsanis E. Zeng Y, et al. Among authors: graner mw. Blood. 2005 Mar 1;105(5):2016-22. doi: 10.1182/blood-2004-05-1915. Epub 2004 Sep 16. Blood. 2005. PMID: 15374884 Free PMC article.

6

Chaperone-rich cell lysates, immune activation and tumor vaccination.

Zeng Y, Graner MW, Katsanis E. Zeng Y, et al. Among authors: graner mw. Cancer Immunol Immunother. 2006 Mar;55(3):329-38. doi: 10.1007/s00262-005-0694-1. Epub 2005 May 11. Cancer Immunol Immunother. 2006. PMID: 15887013 Free PMC article. Review.

7

Peritransplantation vaccination with chaperone-rich cell lysate induces antileukemia immunity.

Chen X, Zeng Y, Li G, Larmonier N, Graner MW, Katsanis E. Chen X, et al. Among authors: graner mw. Biol Blood Marrow Transplant. 2006 Mar;12(3):275-83. doi: 10.1016/j.bbmt.2006.01.001. Biol Blood Marrow Transplant. 2006. PMID: 16503496 Free article.

8

Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells.

Feng H, Zeng Y, Graner MW, Katsanis E. Feng H, et al. Among authors: graner mw. Blood. 2002 Dec 1;100(12):4108-15. doi: 10.1182/blood-2002-05-1389. Epub 2002 Jul 25. Blood. 2002. PMID: 12393401 Free article.

9

Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity.

Feng H, Zeng Y, Graner MW, Likhacheva A, Katsanis E. Feng H, et al. Among authors: graner mw. Blood. 2003 Jan 1;101(1):245-52. doi: 10.1182/blood-2002-05-1580. Epub 2002 Aug 22. Blood. 2003. PMID: 12393411 Free article.

10

Chaperone-rich cell lysate embedded with BCR-ABL peptide demonstrates enhanced anti-tumor activity against a murine BCR-ABL positive leukemia.

Kislin KL, Marron MT, Li G, Graner MW, Katsanis E. Kislin KL, et al. Among authors: graner mw. FASEB J. 2007 Jul;21(9):2173-84. doi: 10.1096/fj.06-7843com. Epub 2007 Feb 27. FASEB J. 2007. PMID: 17327358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters